BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27356742)

  • 1. Thyroid functional parameters and correlative autoantibodies as prognostic factors for differentiated thyroid cancers.
    Li C; Yu W; Fan J; Li G; Tao X; Feng Y; Sun R
    Oncotarget; 2016 Aug; 7(31):49930-49938. PubMed ID: 27356742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
    McLeod DS; Cooper DS; Ladenson PW; Ain KB; Brierley JD; Fein HG; Haugen BR; Jonklaas J; Magner J; Ross DS; Skarulis MC; Steward DL; Maxon HR; Sherman SI;
    Thyroid; 2014 Jan; 24(1):35-42. PubMed ID: 23731273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
    Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
    Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of preoperative anti-thyroglobulin antibody in differentiated thyroid cancer.
    Jo K; Kim MH; Ha J; Lim Y; Lee S; Bae JS; Jung CK; Kang MI; Cha BY; Lim DJ
    Clin Endocrinol (Oxf); 2017 Sep; 87(3):292-299. PubMed ID: 28493284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation analyses of thyroid-stimulating hormone and thyroid autoantibodies with differentiated thyroid cancer.
    Zhang X; Zhang X; Chang Z; Wu C; Guo H
    J BUON; 2018; 23(5):1467-1471. PubMed ID: 30570874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
    Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS
    Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating Antithyroglobulin Antibody As a Prognostic Marker for Differentiated Thyroid Cancer: A Meta-Analysis and Systematic Review.
    Lee ZJO; Eslick GD; Edirimanne S
    Thyroid; 2020 Nov; 30(11):1601-1612. PubMed ID: 32345152
    [No Abstract]   [Full Text] [Related]  

  • 8. High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma.
    Qin J; Yu Z; Guan H; Shi L; Liu Y; Zhao N; Shan Z; Han C; Li Y; Teng W
    Dis Markers; 2015; 2015():648670. PubMed ID: 26600670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
    Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
    Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules.
    Kim ES; Lim DJ; Baek KH; Lee JM; Kim MK; Kwon HS; Song KH; Kang MI; Cha BY; Lee KW; Son HY
    Thyroid; 2010 Aug; 20(8):885-91. PubMed ID: 20465529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-Operative Antithyroid Antibodies in Differentiated Thyroid Cancer.
    Noel JE; Thatipamala P; Hung KS; Chen J; Shi RZ; Orloff LA
    Endocr Pract; 2021 Nov; 27(11):1114-1118. PubMed ID: 34217894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic Predictive Factors of Cervical Lymph Node Metastasis in Differentiated Thyroid Cancer.
    Sun R; Zhang H; Liu K; Fan J; Li G; Song X; Li C
    Acta Otorrinolaringol Esp (Engl Ed); 2018; 69(3):149-155. PubMed ID: 29162220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies.
    Spencer C; LoPresti J; Fatemi S
    Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):394-404. PubMed ID: 25122493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer.
    Aras G; Gültekin SS; Küçük NO
    Nucl Med Commun; 2008 Oct; 29(10):880-4. PubMed ID: 18769305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.
    Rinaldi S; Plummer M; Biessy C; Tsilidis KK; Østergaard JN; Overvad K; Tjønneland A; Halkjaer J; Boutron-Ruault MC; Clavel-Chapelon F; Dossus L; Kaaks R; Lukanova A; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Lund E; Quirós JR; Agudo A; Molina E; Larrañaga N; Navarro C; Ardanaz E; Manjer J; Almquist M; Sandström M; Hennings J; Khaw KT; Schmidt J; Travis RC; Byrnes G; Scalbert A; Romieu I; Gunter M; Riboli E; Franceschi S
    J Natl Cancer Inst; 2014 Jun; 106(6):dju097. PubMed ID: 24824312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Lymph Node Metastasis on Change of Positive Thyroglobulin Antibody in Differentiated Thyroid Carcinoma after Initial Treatment.
    Zhang T; Song LP; Zhao T; Gao W; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):539-543. PubMed ID: 28877833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
    Spencer CA
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls.
    Spencer CA; Wang CC
    Endocrinol Metab Clin North Am; 1995 Dec; 24(4):841-63. PubMed ID: 8608781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlations of serum TgAb and TPOAb and clinicopathological features of PTC in children and adolescents].
    Huang DM; Zhi JT; Zhang JM; Zheng XQ; Zhao JZ; Wei SF; Gao M
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1418-1425. PubMed ID: 36707945
    [No Abstract]   [Full Text] [Related]  

  • 20. Establishment of reference distributions and decision values for thyroid antibodies against thyroid peroxidase (TPOAb), thyroglobulin (TgAb) and the thyrotropin receptor (TRAb).
    Jensen EA; Petersen PH; Blaabjerg O; Hansen PS; Brix TH; Hegedüs L
    Clin Chem Lab Med; 2006; 44(8):991-8. PubMed ID: 16879067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.